Published in Gastroenterology on May 01, 1993
Loss of parietal cell expression of Sonic hedgehog induces hypergastrinemia and hyperproliferation of surface mucous cells. Gastroenterology (2009) 1.55
Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradication. Gut (1999) 1.44
Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest (2007) 1.31
Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut (1996) 1.26
Efficacy of cetuximab in the treatment of Menetrier's disease. Sci Transl Med (2009) 1.14
Distinguishing Ménétrier's disease from its mimics. Gut (2010) 1.12
Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol (1995) 1.11
Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol (1998) 1.11
Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma. J Clin Pathol (1994) 0.94
Any role left for invasive tests? Histology in clinical practice. Gut (1998) 0.93
Pierre Ménétrier and his disease. Trans Am Clin Climatol Assoc (2012) 0.85
The Association of Ménétrier Disease with Ulcerative Colitis: A Case Report with Implications on the Pathogenesis of Ménétrier Disease. Case Rep Gastroenterol (2010) 0.83
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release. World J Gastroenterol (2012) 0.82
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. Dig Dis Sci (1999) 0.81
Endoscopic ultrasonography in the diagnosis of hypertrophic gastropathy. Gastroenterology (1994) 0.78
The role of Sonic Hedgehog as a regulator of gastric function and differentiation. Vitam Horm (2012) 0.77
Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol (2009) 0.77
Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemia. Dig Dis Sci (1999) 0.77
Ménétrier's Disease: Its Mimickers and Pathogenesis. J Pathol Transl Med (2015) 0.75
Ménétrier's disease. Gut (2007) 0.75
Ménétrier's disease. Gut (1995) 0.75
Early gastric cancer in Menetrier's disease. BMJ Case Rep (2009) 0.75
A case of cytomegalovirus-negative Ménétrier's disease with eosinophilia in a child. Korean J Pediatr (2012) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc (1987) 1.78
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol (1999) 1.73
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70
Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology (1986) 1.69
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther (2014) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust (2000) 1.63
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology (1995) 1.59
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc (1990) 1.59
Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil (2005) 1.56
ABC of the upper gastrointestingal tract: Indigestion: When is it functional? BMJ (2001) 1.56
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55
Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg (1992) 1.54
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther (2007) 1.51
Visceral perception in functional gastro-intestinal disorders: disease marker or epiphenomenon? Dig Dis (1997) 1.51
Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study. Aliment Pharmacol Ther (2000) 1.51
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther (2011) 1.49
Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol (1997) 1.48
Management of gastro-oesophageal reflux disease in general practice. BMJ (2001) 1.48
Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc (1992) 1.46
Abuse and functional gastrointestinal disorders: what is the link and should we care? Gastroenterology (1996) 1.46
Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther (2008) 1.46
Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis (2009) 1.45
Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther (2012) 1.45
Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol (2001) 1.43
Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol (1998) 1.43
Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci (1995) 1.41
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol (2000) 1.39
Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol (1996) 1.38
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol (2001) 1.37
Cystic pancreatic tumors: CT and sonographic assessment. AJR Am J Roentgenol (1988) 1.36
Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J (2000) 1.34
Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther (2004) 1.33
Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol (1998) 1.33
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther (2007) 1.32